These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 11774957

  • 1. Relationship between Helicobacter pylori CagA status and colorectal cancer.
    Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J.
    Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957
    [Abstract] [Full Text] [Related]

  • 2. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC, Konturek SJ, Bielanski W, Karczewska E, Pierzchalski P, Duda A, Starzynska T, Marlicz K, Popiela T, Hartwich A, Hahn EG.
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M.
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [Abstract] [Full Text] [Related]

  • 4. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M, Engstrand L, Hansson LE, Bergström R, Wadström T, Nyrén O.
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [Abstract] [Full Text] [Related]

  • 5. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M, Starzyńska T.
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH.
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [Abstract] [Full Text] [Related]

  • 7. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
    Maeda S, Yoshida H, Ogura K, Yamaji Y, Ikenoue T, Mitsushima T, Tagawa H, Kawaguchi R, Mori K, Mafune Ki, Kawabe T, Shiratori Y, Omata M.
    Cancer; 2000 Apr 01; 88(7):1530-5. PubMed ID: 10738209
    [Abstract] [Full Text] [Related]

  • 8. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
    Kikuchi S, Crabtree JE, Forman D, Kurosawa M.
    Am J Gastroenterol; 1999 Dec 01; 94(12):3455-9. PubMed ID: 10606302
    [Abstract] [Full Text] [Related]

  • 9. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G, Cullings H, Fujiwara S, Hattori N, Matsuura S, Hakoda M, Akahoshi M, Kodama K, Tahara E.
    Cancer Epidemiol Biomarkers Prev; 2007 Jun 01; 16(6):1224-8. PubMed ID: 17548689
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
    Beales IL, Crabtree JE, Scunes D, Covacci A, Calam J.
    Eur J Gastroenterol Hepatol; 1996 Jul 01; 8(7):645-9. PubMed ID: 8853252
    [Abstract] [Full Text] [Related]

  • 11. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 01; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

  • 12. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers.
    Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 01; 11(10 Pt 1):1095-9. PubMed ID: 12376513
    [Abstract] [Full Text] [Related]

  • 13. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.
    Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A.
    Cancer Res; 1995 May 15; 55(10):2111-5. PubMed ID: 7743510
    [Abstract] [Full Text] [Related]

  • 14. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
    Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF.
    Cancer Res; 1998 Feb 15; 58(4):588-90. PubMed ID: 9485003
    [Abstract] [Full Text] [Related]

  • 15. Association of Helicobacter pylori-related distal gastric cancer with the HLA class II gene DQB10602 and cagA strains in a southern European population.
    Quintero E, Pizarro MA, Rodrigo L, Piqué JM, Lanas A, Ponce J, Miño G, Gisbert J, Jurado A, Herrero MJ, Jiménez A, Torrado J, Ponte A, Díaz-de-Rojas F, Salido E.
    Helicobacter; 2005 Feb 15; 10(1):12-21. PubMed ID: 15691311
    [Abstract] [Full Text] [Related]

  • 16. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC, Lamarque D, Levy M, Tkoub EM, Copie-Bergman C, Deforges L, Chaumette MT, Haioun C.
    Am J Gastroenterol; 2001 Aug 15; 96(8):2324-8. PubMed ID: 11513169
    [Abstract] [Full Text] [Related]

  • 17. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T, Ren Z, Dunkley M, Clancy R, Maaroos HI, Labotkin R, Kull K, Uibo R.
    APMIS; 2006 May 15; 114(5):372-80. PubMed ID: 16725014
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM, Kolonel LN, Miki K, Stemmermann GN, Wilkens LR, Goodman MT, Perez-Perez GI, Blaser MJ.
    J Infect Dis; 2005 Jun 15; 191(12):2075-81. PubMed ID: 15897993
    [Abstract] [Full Text] [Related]

  • 19. Helicobacter pylori strain types and risk of gastric cancer: a case-control study.
    Enroth H, Kraaz W, Engstrand L, Nyrén O, Rohan T.
    Cancer Epidemiol Biomarkers Prev; 2000 Sep 15; 9(9):981-5. PubMed ID: 11008919
    [Abstract] [Full Text] [Related]

  • 20. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J.
    Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2498-504. PubMed ID: 18768521
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.